CROs/Service Providers

Parexel releases quarterly financial results

Wednesday, May 2, 2012 09:56 AM

Global CRO Parexel International has released its financial results for the third quarter ended March 31, 2012.

More... »

PRA, Amgen collaborate on biosimilar development program

Wednesday, May 2, 2012 09:18 AM

PRA, a global CRO, has formed a strategic relationship with biotech Amgen for a series of phase III studies to develop several biosimilar drugs on a worldwide basis.

More... »

Frontage to develop AtheroNova clinical trial supplies

Friday, April 27, 2012 11:59 AM

Frontage, a global CRO based in Ecton, Penn., has signed an agreement to develop clinical trial supplies with AtheroNova, a biotech company focused on R&D of compounds to regress atherosclerotic plaque.

More... »

Covance-BML lab to expand in Japan

Thursday, April 26, 2012 03:07 PM

CRO Covance of Princeton, N.J., and BML, a Japanese laboratory testing company, will expand the Covance-BML Clinical Trial Laboratory (CB Trial Lab) in Kawagoe City, Saitama Prefecture, to enhance the capacity and capabilities in the region. The companies, which opened the lab together in 2010 as part of a five-year agreement, will launch several new expansion-related services this month.

More... »

Chiltern forms new legal entity In Taiwan

Thursday, April 26, 2012 03:03 PM

CRO Chiltern International has established a new legal entity in Taiwan.

More... »

Report: INC Research to close clinical unit in W. Virginia

Thursday, April 26, 2012 03:01 PM

INC Research of Raleigh, N.C., confirmed it is closing its clinical study unit in Morgantown, W.V., according to an online report in The State Journal.

More... »

Icon reports 10% increase in Q1 2012

Wednesday, April 25, 2012 09:45 AM

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has released its first quarter financial results for 2012, reporting its Q1 net revenues grew 10% year on year to $252.3 million from $229.3 million in Q1 2011.

More... »

Cetero reaches final resolution with FDA

Tuesday, April 24, 2012 03:10 PM

Cary, N.C.-based CRO Cetero Research has reached a final resolution with the FDA over studies the company conducted in its Houston bioanalytical laboratory between April 1, 2005 and June 15, 2010. Following months of open collaboration between Cetero and the agency, the FDA summarized its final decision:

More... »

Iris Pharma, RxGen form strategic alliance

Tuesday, April 24, 2012 12:15 PM

Iris Pharma of France, an ophthalmic preclinical and clinical CRO, and RxGen, a Connecticut-based specialty preclinical CRO focused on the development and application of translational research models, have formed a strategic alliance to offer fully integrated “bench-to-bedside” ophthalmology research services.

More... »

NextBio expands into translational medicine applications

Monday, April 23, 2012 02:47 PM

NextBio of Santa Clara, Calif., has unveiled NextBio Clinical, an extension of the company's existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization.

More... »